Last $46.05 USD
Change Today +0.28 / 0.61%
Volume 11.3M
ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
Frankfurt
As of 8:04 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ABBOTT LABORATORIES (ABT) in the last 6 months

Announced 10/29/14
250.00M for Topera, Inc.
Merger/Acquisition

Abbott Laboratories (NYSE:ABT) signed an agreement to acquire Topera, Inc. from Alafi Capital Company LLC, New Enterprise Associates and others for approximately $250 million in cash on October 29, 2014. Under the terms of the agreement Abbott will pay $250 million upfront, plus potential future payments tied to performance milestones. The deal is subject to customary closing conditions, including antitrust clearance. It is expected to close in the fourth quarter of ...
Read More


ABT's price was unchanged after the transaction was announced on 10/29/14.
Investor / Buyer
Abbott Laboratories
Creditor / Lender
Alafi Capital Company LLC
New Enterprise Associates
Financial Advisor
Merrill Lynch & Co., Inc.
 
Announced 09/11/14
3.00B for Abbott Laboratories
Buyback

Abbott Laboratories (NYSE:ABT) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its shares. The repurchases may be made from time to time as market conditions warrant and subject to regulatory considerations. The company aims to return value to shareholders. The Board of Directors of Abbott Laboratories has authorized a buyback plan on September 11, 2014. On September 11, 2014, the company initiated ...
Read More


ABT's price was unchanged after the transaction was announced on 09/11/14.
 
Announced 07/14/14
5.73B for Abbott Laboratories, Non-U.S. Developed Markets Specialty and Branded Generics Business
Merger/Acquisition

Mylan, Inc. (NasdaqGS:MYL) entered into a business transfer agreement to acquire non-U.S. developed markets specialty and branded generics business of Abbott Laboratories (NYSE:ABT) for approximately $5.3 billion on July 13, 2014. The assets are being acquired on a debt-free basis. In the transaction, Abbott will transfer the assets to Mylan in consideration for 105 million Mylan ordinary shares, representing 21% stake and Mylan will hold 71% stake. Under the agreement, ...
Read More


ABT's price was unchanged after the transaction was announced on 07/14/14.
Investor / Buyer
Mylan, Inc.
Creditor / Lender
Abbott Laboratories
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $46.05 USD +0.28

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $67.71 USD -0.21
Actavis plc $265.39 USD +1.64
Eli Lilly & Co $72.40 USD -0.05
General Mills Inc $53.81 USD +0.30
Novo Nordisk A/S kr266.00 DKK 0.00
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 36.2x
Price/Sales 3.1x
Price/Book 3.0x
Price/Cash Flow 25.6x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.